Home | About PM | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |  Login 
Pharmacognosy Magazine
Search Article 
  
Advanced search 
 
ORIGINAL ARTICLE
Year : 2020  |  Volume : 16  |  Issue : 67  |  Page : 61-67

Bioactivity-guided fractionation of Cymbopogon caesius (Ness) stapf. revealed isoorientin as an antihypertensive agent


1 Department of Chinese Materia Medica, College of Traditional Chinese Medicine, Xinjiang Medical University, Xinjiang, Urumqi, PR China
2 Department of Pharmacy, The Third Affiliated Hospital of Guangxi University of Chinese Medicine, Guangxi, Liuzhou, PR China

Correspondence Address:
Hong Ping Zhang
The Third Affiliated Hospital of Guangxi University of Chinese Medicine, Guangxi, Liuzhou 545001
PR China
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/pm.pm_178_19

Rights and Permissions

Background: Cymbopogon caesius (Ness) Stapf. is a traditional Uyghur medicinal material that is used for the treatment of pain, rheumatism, cold, indigestion, and injury. Objective: The aim of this study was to isolate the antihypertensive activity compounds from C. caesius (Ness) Stapf. Materials and Methods: Cymbopogon caesius (Ness) Stapf. was reflux extracted by EtOH, and the obtained extracts were screened for antihypertensive compounds via the hypertension model of rabbits and rats. The hypertensive extracts were separated via column chromatography and recrystallization and screened for antihypertensive compounds by the hypertension model of rats induced by L-NG-nitroarginine (L-NNA). Their structures were elucidated by nuclear magnetic resonance (NMR) spectroscopy and melt point. Results: Three compounds, namely, isoorientin (Compound I), β-sitosterol (Compound II), and chlorogenic acid (Compound III), were isolated from the dried aerial part of C. caesius (Ness) Stapf. via bioactivity-guided fractionation. Their structures were elucidated by NMR spectroscopy and melt point. Isoorientin may reduce the rats' blood pressure, which was elucidated through the diastolic blood pressure and systolic blood pressure of L-NNA-induced hypertensive rat model experiment. Conclusion: Isoorientin is one of the novel compounds of C. caesius (Ness) Stapf. for the treatment of hypertension diseases.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed44    
    Printed0    
    Emailed0    
    PDF Downloaded13    
    Comments [Add]    

Recommend this journal